Carmen Warren, PhD Kite, a Gilead Company

Carmen Warren is currently the Director of Immune Cell Attribute Sciences within Analytical Development at Kite, a Gilead Company. Carmen leads a team that establishes the analytical control strategy, including identification of Critical Quality Attributes, which informs specification development, comparability, and process validation campaigns to support product development and lifecycle management. Her team drives the continued study of apheresis starting material to understand its impact on autologous cell therapy process and product performance and to identify opportunities for process improvements. Carmen joined Kite in 2019 and has contributed to multiple IND, BLA and PAS filings. Prior to joining Kite, she worked on the development of antibody drug conjugates at Agensys, an affiliate of Astellas Pharma. Carmen obtained a BS in Biochemistry and Cell Biology from the University of California, San Diego and a PhD in Biological Chemistry from the University of California, Los Angeles.